Which of the following is a therapeutic use of erythropoietin? (Select All that Apply.)

A. Erythropoietin stimulates red blood cell production and is used to treat anemia in patients with HIV who are receiving antiretroviral therapy that can suppress bone marrow. B. It is also indicated for chemotherapy-induced anemia, helping reduce fatigue and the need for blood transfusions. C. Hyperthyroidism is unrelated to erythropoietin therapy; it does not affect thyroid hormone levels. D. Iron-deficiency anemia without renal disease is typically treated with iron supplementation, not erythropoietin, unless there is concurrent bone marrow suppression. E. Chronic kidney disease often causes anemia due to reduced endogenous erythropoietin production; exogenous erythropoietin is used therapeutically in these patients. F. Prevention of blood clots is not a function of erythropoietin; anticoagulants are used for that purpose. G. Reduction of blood pressure is not an effect of erythropoietin; it may even increase blood pressure in some patients. H. Thrombocytopenia treatment is not indicated with erythropoietin; platelet growth factors or other therapies are used instead.